We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$11.2B
AUM Growth
+$940M
Cap. Flow
+$1.12B
Cap. Flow %
10.03%
Top 10 Hldgs %
10.74%
Holding
2,900
New
574
Increased
959
Reduced
752
Closed
610

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$93.4M
2
AAPL icon
Apple
AAPL
+$80.7M
3
DRI icon
Darden Restaurants
DRI
+$70M
4
CVS icon
CVS Health
CVS
+$63.6M
5
V icon
Visa
V
+$54.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.85%
2 Technology 11.68%
3 Financials 10.7%
4 Healthcare 9.66%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIT icon
2151
XBiotech
XBIT
$69.2M
$135K ﹤0.01%
+12,888
New +$105K
PCYO icon
2152
Pure Cycle
PCYO
$257M
$134K ﹤0.01%
+13,041
New +$139K
ACTG icon
2153
Acacia Research
ACTG
$450M
$132K ﹤0.01%
49,221
-1,121
-2% -$3.13K
AXTI icon
2154
AXT Inc
AXTI
$3.09B
$131K ﹤0.01%
36,825
+9,620
+35% +$37K
AQST icon
2155
Aquestive Therapeutics
AQST
$462M
$130K ﹤0.01%
40,777
+2,587
+7% +$9.69K
TPST icon
2156
Tempest Therapeutics
TPST
$14.8M
$130K ﹤0.01%
94
+41
+77% +$66.2K
TBIO
2157
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$128K ﹤0.01%
+12,914
New +$122K
CRBP icon
2158
Corbus Pharmaceuticals
CRBP
$170M
$127K ﹤0.01%
+872
New +$152K
KT icon
2159
KT
KT
$8.84B
$126K ﹤0.01%
+11,119
New +$128K
ORC
2160
Orchid Island Capital
ORC
$1.31B
$125K ﹤0.01%
+4,335
New +$131K
YRD
2161
Yiren Digital
YRD
$103M
$125K ﹤0.01%
+17,790
New +$183K
RKDA icon
2162
Arcadia Biosciences
RKDA
$1.4M
$124K ﹤0.01%
+661
New +$127K
LBRT icon
2163
Liberty Energy
LBRT
$2.83B
$120K ﹤0.01%
11,100
-11,520
-51% -$141K
RNET
2164
DELISTED
RigNet, Inc.
RNET
$120K ﹤0.01%
15,510
-21,327
-58% -$180K
CRON
2165
Cronos Group
CRON
$1.05B
$119K ﹤0.01%
+13,200
New +$169K
TLRA
2166
DELISTED
Telaria, Inc.
TLRA
$119K ﹤0.01%
17,171
-222,229
-93% -$1.85M
BKD icon
2167
Brookdale Senior Living
BKD
$3.62B
$118K ﹤0.01%
15,522
-46,021
-75% -$364K
IDYA icon
2168
IDEAYA Biosciences
IDYA
$3.41B
$118K ﹤0.01%
+13,132
New +$100K
QUAD icon
2169
Quad
QUAD
$430M
$117K ﹤0.01%
+11,168
New +$104K
OPTN
2170
DELISTED
OptiNose
OPTN
$113K ﹤0.01%
+1,074
New +$107K
BCIC
2171
BCP Investment Corp
BCIC
$86.9M
$113K ﹤0.01%
5,040
+1,361
+37% +$31.7K
ESI icon
2172
Element Solutions
ESI
$9.12B
$112K ﹤0.01%
10,967
-31,619
-74% -$311K
GERN icon
2173
Geron
GERN
$911M
$112K ﹤0.01%
84,084
+31,150
+59% +$41.7K
FTSI
2174
DELISTED
FTS International, Inc. Common Stock
FTSI
$112K ﹤0.01%
2,495
-4,978
-67% -$358K
WNEB icon
2175
Western New England Bancorp
WNEB
$287M
$111K ﹤0.01%
+11,598
New +$107K

Similar funds

Squarepoint's Q3 2019 Portfolio in Review

As of Q3 2019, Squarepoint held 2,900 positions worth $11.2B, up 9.2% from $10.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Squarepoint deployed $1.12B of net new capital in Q3 2019, opening 574 new positions and adding to 959 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $93.4M trimmed.

  • Squarepoint's largest Q3 2019 buy was State Street Communication Services Select Sector SPDR ETF: 3,258,265 shares worth $161M.
  • Squarepoint added most to Costco in Q3 2019, an estimated $137M increase.
  • Squarepoint's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $93.4M.
  • Squarepoint fully exited Visa in Q3 2019, selling an estimated $54.9M.
  • Squarepoint's ten largest holdings make up 11% of its $11.2B portfolio in Q3 2019.
  • Squarepoint opened 574 new positions and closed 610 in Q3 2019.
  • Squarepoint's portfolio value rose 9.2% quarter-over-quarter to $11.2B.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.